Position in AVIR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,398,517
-$659,526 QoQ
Shares Held
945,918
+0.6% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. AVIR ranks #120 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,398,517 | 945,918 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,058,043 | 940,157 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,813,407 | 1,348,294 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,788,866 | 616,851 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $2,349,578 | 652,661 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,311,917 | 773,217 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,371,015 | 409,259 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $319,066 | 95,244 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $152,974 | 46,216 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $417,153 | 103,256 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $208,699 | 68,426 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $205,191 | 68,397 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $235,233 | 62,897 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $208,413 | 62,213 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $1,010,185 | 210,018 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,052,898 | 185,044 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $316,694 | 44,605 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,585,510 | 219,600 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $410,524 | 45,920 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,537,379 | 43,850 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $595,146 | 27,707 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $506,226 | 8,198 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,634,683 | 39,126 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||